209 related articles for article (PubMed ID: 9845355)
1. Upregulation of caveolin-1 and caveolae organelles in Taxol-resistant A549 cells.
Yang CP; Galbiati F; Volonte D; Horwitz SB; Lisanti MP
FEBS Lett; 1998 Nov; 439(3):368-72. PubMed ID: 9845355
[TBL] [Abstract][Full Text] [Related]
2. Role of caveolin-1 in etoposide resistance development in A549 lung cancer cells.
Bélanger MM; Gaudreau M; Roussel E; Couet J
Cancer Biol Ther; 2004 Oct; 3(10):954-9. PubMed ID: 15326378
[TBL] [Abstract][Full Text] [Related]
3. Mechanistic analysis of taxol-induced multidrug resistance in an ovarian cancer cell line.
Wang NN; Zhao LJ; Wu LN; He MF; Qu JW; Zhao YB; Zhao WZ; Li JS; Wang JH
Asian Pac J Cancer Prev; 2013; 14(9):4983-8. PubMed ID: 24175763
[TBL] [Abstract][Full Text] [Related]
4. Taxol and discodermolide represent a synergistic drug combination in human carcinoma cell lines.
Martello LA; McDaid HM; Regl DL; Yang CP; Meng D; Pettus TR; Kaufman MD; Arimoto H; Danishefsky SJ; Smith AB; Horwitz SB
Clin Cancer Res; 2000 May; 6(5):1978-87. PubMed ID: 10815923
[TBL] [Abstract][Full Text] [Related]
5. G2/M blockade by paclitaxel induces caveolin-1 expression in A549 lung cancer cells: caveolin-1 as a marker of cytotoxicity.
Roussel E; Bélanger MM; Couet J
Anticancer Drugs; 2004 Nov; 15(10):961-7. PubMed ID: 15514565
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling of epothilone A-resistant cells.
Atadja P; Yan-Neale Y; Towbin H; Buxton F; Cohen D
Novartis Found Symp; 2002; 243():119-32; discussion 132-6, 180-5. PubMed ID: 11990772
[TBL] [Abstract][Full Text] [Related]
7. Epothilone B stabilizes microtubuli of macrophages like taxol without showing taxol-like endotoxin activity.
Muhlradt PF; Sasse F
Cancer Res; 1997 Aug; 57(16):3344-6. PubMed ID: 9269992
[TBL] [Abstract][Full Text] [Related]
8. Up-regulation of caveolae and caveolar constituents in multidrug-resistant cancer cells.
Lavie Y; Fiucci G; Liscovitch M
J Biol Chem; 1998 Dec; 273(49):32380-3. PubMed ID: 9829965
[TBL] [Abstract][Full Text] [Related]
9. Overcoming Taxol-resistance in A549 cells: A comprehensive strategy of targeting P-gp transporter, AKT/ERK pathways, and cytochrome P450 enzyme CYP1B1 by 4-hydroxyemodin.
Lin H; Hu B; He X; Mao J; Wang Y; Wang J; Zhang T; Zheng J; Peng Y; Zhang F
Biochem Pharmacol; 2020 Jan; 171():113733. PubMed ID: 31783010
[TBL] [Abstract][Full Text] [Related]
10. Epothilones, a new class of microtubule-stabilizing agents with a taxol-like mechanism of action.
Bollag DM; McQueney PA; Zhu J; Hensens O; Koupal L; Liesch J; Goetz M; Lazarides E; Woods CM
Cancer Res; 1995 Jun; 55(11):2325-33. PubMed ID: 7757983
[TBL] [Abstract][Full Text] [Related]
11. Acquisition of taxol resistance via P-glycoprotein- and non-P-glycoprotein-mediated mechanisms in human ovarian carcinoma cells.
Parekh H; Wiesen K; Simpkins H
Biochem Pharmacol; 1997 Feb; 53(4):461-70. PubMed ID: 9105396
[TBL] [Abstract][Full Text] [Related]
12. Caveolin-1 regulates cell apoptosis and invasion ability in paclitaxel-induced multidrug-resistant A549 lung cancer cells.
Han F; Zhang L; Zhou Y; Yi X
Int J Clin Exp Pathol; 2015; 8(8):8937-47. PubMed ID: 26464635
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of caveolin expression by cytotoxic agents in drug-sensitive cancer cells.
Bélanger MM; Roussel E; Couet J
Anticancer Drugs; 2003 Apr; 14(4):281-7. PubMed ID: 12679732
[TBL] [Abstract][Full Text] [Related]
14. Multidrug resistance phenotype and paclitaxel (Taxol) sensitivity in human renal carcinoma cell lines of different histologic types.
Reinecke P; Schmitz M; Schneider EM; Gabbert HE; Gerharz CD
Cancer Invest; 2000; 18(7):614-25. PubMed ID: 11036469
[TBL] [Abstract][Full Text] [Related]
15. BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy.
Lee FY; Borzilleri R; Fairchild CR; Kim SH; Long BH; Reventos-Suarez C; Vite GD; Rose WC; Kramer RA
Clin Cancer Res; 2001 May; 7(5):1429-37. PubMed ID: 11350914
[TBL] [Abstract][Full Text] [Related]
16. Resistance to Taxol in lung cancer cells associated with increased microtubule dynamics.
Gonçalves A; Braguer D; Kamath K; Martello L; Briand C; Horwitz S; Wilson L; Jordan MA
Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11737-42. PubMed ID: 11562465
[TBL] [Abstract][Full Text] [Related]
17. Activities of the microtubule-stabilizing agents epothilones A and B with purified tubulin and in cells resistant to paclitaxel (Taxol(R)).
Kowalski RJ; Giannakakou P; Hamel E
J Biol Chem; 1997 Jan; 272(4):2534-41. PubMed ID: 8999970
[TBL] [Abstract][Full Text] [Related]
18. YAN, a novel microtubule inhibitor, inhibits P-gp and MRP1 function and induces mitotic slippage followed by apoptosis in multidrug-resistant A549/Taxol cells.
Gao M; Liu T; Li J; Guan Q; Wang H; Yan S; Li Z; Zuo D; Zhang W; Wu Y
Toxicol In Vitro; 2020 Dec; 69():104971. PubMed ID: 32805372
[TBL] [Abstract][Full Text] [Related]
19. Pregnane X receptors regulate CYP2C8 and P-glycoprotein to impact on the resistance of NSCLC cells to Taxol.
Chen Y; Huang W; Chen F; Hu G; Li F; Li J; Xuan A
Cancer Med; 2016 Dec; 5(12):3564-3571. PubMed ID: 27878971
[TBL] [Abstract][Full Text] [Related]
20. Triptolide reverses the Taxol resistance of lung adenocarcinoma by inhibiting the NF-κB signaling pathway and the expression of NF-κB-regulated drug-resistant genes.
Jiang N; Dong XP; Zhang SL; You QY; Jiang XT; Zhao XG
Mol Med Rep; 2016 Jan; 13(1):153-9. PubMed ID: 26531258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
